GlaxoSmithKline plc (GSK.L)
LSE - LSE Delayed price. Currency in GBp
Add to watchlist
1,548.20-25.00 (-1.59%)
As of 1:25PM BST. Market open.
| Previous close | 1,573.20 |
| Open | 1,567.00 |
| Bid | 1,548.00 x 0 |
| Ask | 1,548.20 x 0 |
| Day's range | 1,540.40 - 1,571.20 |
| 52-week range | 16.27 - 1,857.00 |
| Volume | 1,599,348 |
| Avg. volume | 8,405,597 |
| Market cap | 77.679B |
| Beta (5Y monthly) | 0.42 |
| PE ratio (TTM) | 11.67 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.76 (4.83%) |
| Ex-dividend date | 13 Aug 2020 |
| 1y target est | N/A |
- Business Wire
FDA Approves GSK’s BLENREP (belantamab mafodotin-blmf) for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma
FDA Approves GSK’s BLENREP (belantamab mafodotin-blmf) for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma.
- Business Wire
GSK Presents New Data from the GARNET Study Demonstrating Potential of Dostarlimab to Treat a Subset of Women with Recurrent or Advanced Endometrial Cancer
GSK presents new data from GARNET study demonstrating potential of dostarlimab to treat subset of women with recurrent or advanced endometrial cancer
© 2020 Verizon Media. All rights reserved.
